menu toggle

Insights

US capitol color

Insight

Gauge the impact: What does the striking down of a federal copay accumulator regulation mean for patients and copay programs?

AmerisourceBergen
October 2023

Learn more
Washington DC Capital

Insight

First 10 drugs for Medicare price negotiation announced under IRA

Corey Ford, MHA
August 2023

Read more
abstract lines

Insight

Issue Brief: Assessing the impact of formulary exclusion on healthcare costs and outcomes for patients on therapy for certain chronic conditions

Xcenda
May 2023

Learn more
Team members at the AMCP 2023 exhibit

Insight

Recap AMCP 2023: Our thought leadership in action

Xcenda
March 2023

Learn more
Abstract photography showing blue and white lines with a sense of motion

Insight

Optimize your pre-approval information exchange strategy

Charles Dragovich
March 2023

Read more
senior in exam office with provider

Insight

Medicare cannot age in place: A diversifying population requires policy evolution

Xcenda
March 2023

Learn more
HTA Quarterly Logo

Insight

HTA Quarterly | Summer 2023

Xcenda
November 2022

Learn more
HTA Quarterly Logo

Insight

HTA Quarterly | Winter 2022

Xcenda
October 2022

Learn more
HTA Quarterly Logo

Insight

HTA Quarterly | Winter 2022

Xcenda
October 2022

Learn more
AB color abstract

Insight

Closing the Gaps in Pre-Approval Information Exchange to Accelerate Product Success and Patient Access

Xcenda
August 2022

Learn more
HTA Quarterly Logo

Insight

HTA Quarterly | Fall 2022

HTA Quarterly
August 2022

Learn more
Reform in front of money

Insight

Upcoming cost-containing measures in Germany—How will they affect the biopharmaceutical industry?

HTA Quarterly
August 2022

Learn more
Abstract image of Red Color Illuminated Fiber Optics Selective Focus on Blue Background.

Insight

Market access abroad: Three reasons why early planning is critical for HTA countries

AmerisourceBergen
August 2022

Read more
AB abstract

Insight

Skyrocketing growth in PBM formulary exclusions continues to raise concerns about patient access

Xcenda
May 2022

Learn more
petri dish

Insight

Medicaid Best Price and Its Implications on Cell and Gene Therapy Products

Xcenda
April 2022

Learn more
Debunking PIE misperceptions

Insight

Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics

Xcenda
March 2022

Learn more
Healthcare provider with Canadian flag

Insight

The drug reimbursement environment in Canada: An overview

Xcenda
February 2022

Learn more
UK innovative licensing

Insight

The UK Innovative Licensing and Access Pathway—A new paradigm in market access

Xcenda
February 2022

Learn more
Xcenda_2_3_Card-02

Insight

HTA Quarterly | Spring 2022

Xcenda
February 2022

Learn more
Abstract image

Insight

Accelerated approval not accelerated access: Clinical trials required for coverage of Alzheimer's treatments

Xcenda
February 2022

Learn more

Insight

The impact of the Build Back Better Act (BBBA) on rare disease innovation

Xcenda
December 2021

Learn more
Xcenda_2_3_Card-02

Insight

HTA Quarterly | Winter 2021

Xcenda
November 2021

Learn more
Globe with communication lines from UK

Insight

Is NICE becoming nicer?

Xcenda
November 2021

Learn more
abstract waves

Insight

340B – A missed opportunity to address those that are medically underserved

Xcenda
November 2021

Learn more
Hands holding coins

Insight

Health disparities and health technology assessment: Current value assessment frameworks fall short

Xcenda
August 2021

Learn more
Abstract figure pushing pill up with US dollar sign

Insight

Elucidating ICER’s methodologies for Unsupported Price Increase assessments  

Xcenda
August 2021

Learn more
abstract lines

Insight

Equity considerations in US value assessment: Opportunities ahead

Xcenda
August 2021

Learn more
abstract lines

Insight

Affordability is about more than drug prices

Xcenda
July 2021

Learn more
scanning pharmacy product

Insight

Copay accumulators and the impact on patients

Corey Ford, MHA
June 2021

Learn more
copay accumulator piggy bank

Insight

Strategies for addressing copay accumulators: What manufacturers need to know

Corey Ford, MHA; Dale Hanna
March 2021

Read more
outline of people with virus background

Insight

The impact of obesity on COVID-19 outcomes of hospitalizations and mortality

Xcenda
January 2021

Learn more
telehealth visit

Insight

It’s the Healthcare of the Future: Telehealth Trends Beyond 2020

Xcenda
November 2020

Learn more
Republican Democrat Healthcare

Insight

Let's Ditch 2020 and Plan for 2021: Election What-Ifs

Xcenda
October 2020

Learn more
Group of professional discussing around a table

Insight

Impact of First Dollar Coverage for Insulin

Xcenda
October 2020

Learn more

Insight

Webinar: Navigating Pre-approval Information Exchange (PIE) and the AMCP Format for Formulary Submissions, Version 4.1

Xcenda
May 2020

This webinar will provide an overview of pre-approval information exchange (PIE), review the changes and discuss the implications of the recently released AMCP Format v4.1, and provide manufacturer considerations and recommendations for PIE and the pre-approval dossier.

Learn more
Pill in palm of hand

Insight

Impact of COVID-19 Pandemic on Patient Access Programs

Xcenda
April 2020

Learn more
MindtheGap

Insight

Mind the (Evidence) Gap

Kim McLeod, MPH
Xcenda
February 2020

Learn more

Insight

Effectively Communicating Pipeline Information to Drive Payers Attention

Xcenda
November 2019

Learn more
Loading...